174 related articles for article (PubMed ID: 37202395)
1. Identification of age-specific gene regulators of La Crosse virus neuroinvasion and pathogenesis.
Basu R; Ganesan S; Winkler CW; Anzick SL; Martens C; Peterson KE; Fraser IDC
Nat Commun; 2023 May; 14(1):2836. PubMed ID: 37202395
[TBL] [Abstract][Full Text] [Related]
2. Age influences susceptibility of brain capillary endothelial cells to La Crosse virus infection and cell death.
Basu R; Nair V; Winkler CW; Woods TA; Fraser IDC; Peterson KE
J Neuroinflammation; 2021 Jun; 18(1):125. PubMed ID: 34082753
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent myeloid dendritic cell responses mediate resistance to la crosse virus-induced neurological disease.
Taylor KG; Woods TA; Winkler CW; Carmody AB; Peterson KE
J Virol; 2014 Oct; 88(19):11070-9. PubMed ID: 25008929
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytes have a role in protection, but not in pathogenesis, during La Crosse Virus infection in mice.
Winkler CW; Myers LM; Woods TA; Carmody AB; Taylor KG; Peterson KE
J Neuroinflammation; 2017 Mar; 14(1):62. PubMed ID: 28340587
[TBL] [Abstract][Full Text] [Related]
5. Targeted Mutations in the Fusion Peptide Region of La Crosse Virus Attenuate Neuroinvasion and Confer Protection against Encephalitis.
Hollidge BS; Salzano MV; Ibrahim JM; Fraser JW; Wagner V; Leitner NE; Weiss SR; Weber F; González-Scarano F; Soldan SS
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891445
[TBL] [Abstract][Full Text] [Related]
6. La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.
Bennett RS; Cress CM; Ward JM; Firestone CY; Murphy BR; Whitehead SS
Virol J; 2008 Feb; 5():25. PubMed ID: 18267012
[TBL] [Abstract][Full Text] [Related]
7. Capillaries in the olfactory bulb but not the cortex are highly susceptible to virus-induced vascular leak and promote viral neuroinvasion.
Winkler CW; Race B; Phillips K; Peterson KE
Acta Neuropathol; 2015 Aug; 130(2):233-45. PubMed ID: 25956408
[TBL] [Abstract][Full Text] [Related]
8. A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.
Bennett RS; Gresko AK; Nelson JT; Murphy BR; Whitehead SS
J Virol; 2012 Jan; 86(1):420-6. PubMed ID: 22013033
[TBL] [Abstract][Full Text] [Related]
9. The La Crosse virus class II fusion glycoprotein
Thannickal SA; Spector SN; Stapleford KA
J Virol; 2023 Aug; 97(8):e0081923. PubMed ID: 37578236
[TBL] [Abstract][Full Text] [Related]
10. Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes.
Bennett RS; Ton DR; Hanson CT; Murphy BR; Whitehead SS
Virol J; 2007 May; 4():41. PubMed ID: 17488515
[TBL] [Abstract][Full Text] [Related]
11. Comparative sequence analyses of La Crosse virus strain isolated from patient with fatal encephalitis, Tennessee, USA.
Lambert AJ; Fryxell RT; Freyman K; Ulloa A; Velez JO; Paulsen D; Lanciotti RS; Moncayo A
Emerg Infect Dis; 2015 May; 21(5):833-6. PubMed ID: 25898269
[TBL] [Abstract][Full Text] [Related]
12. La Crosse Virus in Aedes japonicus japonicus mosquitoes in the Appalachian Region, United States.
Harris MC; Dotseth EJ; Jackson BT; Zink SD; Marek PE; Kramer LD; Paulson SL; Hawley DM
Emerg Infect Dis; 2015 Apr; 21(4):646-9. PubMed ID: 25811131
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of infectivity of insect cell-derived La Crosse Virus by human serum.
Cruz MA; Parks GD
Virus Res; 2021 Jan; 292():198228. PubMed ID: 33188797
[TBL] [Abstract][Full Text] [Related]
14. La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic.
Soldan SS; Hollidge BS; Wagner V; Weber F; González-Scarano F
Virology; 2010 Sep; 404(2):139-47. PubMed ID: 20553924
[TBL] [Abstract][Full Text] [Related]
15. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.
Blakqori G; Delhaye S; Habjan M; Blair CD; Sánchez-Vargas I; Olson KE; Attarzadeh-Yazdi G; Fragkoudis R; Kohl A; Kalinke U; Weiss S; Michiels T; Staeheli P; Weber F
J Virol; 2007 May; 81(10):4991-9. PubMed ID: 17344298
[TBL] [Abstract][Full Text] [Related]
16. Orthobunyavirus entry into neurons and other mammalian cells occurs via clathrin-mediated endocytosis and requires trafficking into early endosomes.
Hollidge BS; Nedelsky NB; Salzano MV; Fraser JW; González-Scarano F; Soldan SS
J Virol; 2012 Aug; 86(15):7988-8001. PubMed ID: 22623766
[TBL] [Abstract][Full Text] [Related]
17. La Crosse Virus Disease in the United States, 2003-2019.
Vahey GM; Lindsey NP; Staples JE; Hills SL
Am J Trop Med Hyg; 2021 Jul; 105(3):807-812. PubMed ID: 34280142
[TBL] [Abstract][Full Text] [Related]
18. Rottlerin inhibits La Crosse virus-induced encephalitis in mice and blocks release of replicating virus from the Golgi body in neurons.
Ojha D; Winkler CW; Leung JM; Woods TA; Chen CZ; Nair V; Taylor K; Yeh CD; Tawa GJ; Larson CL; Zheng W; Haigh CL; Peterson KE
Nat Microbiol; 2021 Nov; 6(11):1398-1409. PubMed ID: 34675384
[TBL] [Abstract][Full Text] [Related]
19. C-C motif chemokine receptor 2 and 7 synergistically control inflammatory monocyte recruitment but the infecting virus dictates monocyte function in the brain.
Winkler CW; Evans AB; Carmody AB; Lack JB; Woods TA; Peterson KE
Commun Biol; 2024 Apr; 7(1):494. PubMed ID: 38658802
[TBL] [Abstract][Full Text] [Related]
20. Differences in neuroinvasion and protective innate immune pathways between encephalitic California Serogroup orthobunyaviruses.
Evans AB; Winkler CW; Peterson KE
PLoS Pathog; 2022 Mar; 18(3):e1010384. PubMed ID: 35245345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
